Aasma Munawwar, Amna Sajjad, Azhar Rasul, Mehran Sattar, & Farhat Jabeen. (2023). Dissecting the Role of SMYD2 and Its Inhibitor (LLY-507) in the Treatment of Chemically Induced Non-Small Cell Lung Cancer (NSCLC) by Using Fe<sub>3</sub>O<sub>4</sub> Nanoparticles Drug Delivery System. MDPI AG.
Chicago Style (17th ed.) CitationAasma Munawwar, Amna Sajjad, Azhar Rasul, Mehran Sattar, and Farhat Jabeen. Dissecting the Role of SMYD2 and Its Inhibitor (LLY-507) in the Treatment of Chemically Induced Non-Small Cell Lung Cancer (NSCLC) by Using Fe<sub>3</sub>O<sub>4</sub> Nanoparticles Drug Delivery System. MDPI AG, 2023.
MLA (9th ed.) CitationAasma Munawwar, et al. Dissecting the Role of SMYD2 and Its Inhibitor (LLY-507) in the Treatment of Chemically Induced Non-Small Cell Lung Cancer (NSCLC) by Using Fe<sub>3</sub>O<sub>4</sub> Nanoparticles Drug Delivery System. MDPI AG, 2023.